Australia to prescribe MDMA and psilocybin for PTSD and depression.
This article says it’ll be the world’s first country to allow it. ~ learn more
This article says it’ll be the world’s first country to allow it. ~ learn more
“Lee was part of a small group — many of them retired athletes — who’d traveled to Jamaica in March 2022 for a retreat costing as much as $5,500. They each had come to the Good Hope Estate, a sugar […]
“In this phase 2 trial involving participants with treatment-resistant depression, psilocybin at a single dose of 25 mg, but not 10 mg, reduced depression scores significantly more than a 1-mg dose over a period of 3 weeks but was associated […]
This modified version of transcranial magnetic stimulation had a success rate of 78% vs 30%, and takes 5 days vs 6 weeks. | learn more
“A small device implanted in the brain of a patient with severe, treatment-resistant depression was trained to issue electrical pulses to areas of the brain linked to the condition. The effects of the neurostimulation kicked in almost immediately, according to […]
“Nushama is a medically supervised psychedelic wellness center that provides intravenous (IV) ketamine for an ego-dissolving psychedelic experience. The center says Ketamine Psychedelic Therapy (KPT) can provide sustained relief from depression, anxiety, chronic pain, addiction and trauma-induced mood disorders.” | learn more
“Early reports from Small Pharma suggest that DMT, in conjunction with therapy, can be used to help break away from undesired behavioral patterns. Other studies also suggest that it could prove useful in helping with depression and anxiety.” | learn more
“The results, recently published in the New England Journal of Medicine, are decidedly mixed with the primary depression measure revealing no significant difference between the two treatments, but a number of secondary measures notably favoring psilocybin.” | learn more
While I’m not in the market for middle school textbooks, I am fond of this one for its approach. Ever since Hans Rosling helped me realize my world view was based on decades-old and outdated data, I’ve wondered if that cycle persists. […]
“Australian scientists have developed a world-first test claimed to accurately measure levels of a brain protein associated with depression and bipolar disorder. The test could offer doctors an objective diagnostic tool to assess patients.” | learn more